REFERENCE
Lui YYN, Tsoi KKF, Wong VWS, Chan HLY.Is the roadmap model cost-effective in the era of tenofovir in the treatment of chronic hepatitis B virus infection? 44th Annual Meeting of the European Association for the Study of the Liver: abstr. 802, 25 Apr 2009. Available from: URL: http://www2.kenes.com
Rights and permissions
About this article
Cite this article
Does the roadmap show the way to cost effectiveness in Hep B?. Pharmacoecon. Outcomes News 578, 5 (2009). https://doi.org/10.2165/00151234-200905780-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905780-00010